Natalizumab Active Not Recruiting Phase 2 Trials for Epilepsy, Focal Seizures, Partial Seizures Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03283371Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy